Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2012
02/02/2012WO2012015674A1 THERAPEUTIC USES OF AN FGFR1c ANTIBODY
02/02/2012WO2012015662A1 Il-18 receptor as a novel target of regulatory t cells in cancer
02/02/2012WO2012015270A2 Permissive cell line to the porcine reproductive and respiratory syndrome virus
02/02/2012WO2012015008A1 Anti-tumor agent
02/02/2012WO2012014978A1 Immune adjuvant
02/02/2012WO2012014945A1 Novel nucleic acid having adjuvant activity and use thereof
02/02/2012WO2012014078A2 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
02/02/2012WO2012013980A1 Stabilized aqueous antibody compositions
02/02/2012WO2012013939A1 Recombinant trypanosoma theileri parasite
02/02/2012WO2012013704A1 Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer
02/02/2012WO2012012874A1 Immunogenic anti-inflammatory compositions
02/02/2012WO2012012872A1 Recombinant bacterium and uses thereof
02/02/2012WO2012012851A1 Recombinant neisseria meningitidis por a porin proteins.
02/02/2012WO2011156594A3 Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
02/02/2012WO2011151726A3 Concentration and lyophilization of influenza vaccine antigens
02/02/2012WO2011151076A3 Monoclonal antibodies targeting amyloid beta oligomers
02/02/2012WO2011145108A3 Purification of capsular polysaccharides
02/02/2012WO2011127302A3 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
02/02/2012WO2011091279A3 Targeted heterologous antigen presentation on calicivirus virus-like particles
02/02/2012WO2011079073A3 Herpes simplex virus vaccines
02/02/2012WO2011008863A4 Stereoisomer peptides and their polymer conjugates for hiv disease
02/02/2012US20120030839 Expression and High-Throughput Screening of Complex Expressed DNA Libraries in Filamentous Fungi
02/02/2012US20120030780 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
02/02/2012US20120029473 Use of 5c8 mab and direct induction of regulatory cd8+ t cells to establish permanent and specific transplantation tolerance
02/02/2012US20120029472 Tnfr25 agonists to enhance immune responses to vaccines
02/02/2012US20120029437 Kits for one-dose intradermal delivery for non-live trivalent influenza vaccine
02/02/2012US20120029173 Attenuated salmonella enterica serovar paratyphi a and uses thereof
02/02/2012US20120028913 Peptides for inhibiting chemokine binding to chemokine receptors
02/02/2012US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
02/02/2012US20120028281 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
02/02/2012US20120028258 Receptor gene screening for detecting or diagnosing cancer
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027841 Novel mucosal vaccination approach for herpes simplex virus type-2
02/02/2012US20120027836 Novel edwardsiella ictaluri e-ict-vl33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
02/02/2012US20120027814 Polymeric Fibers Having Tissue Reactive Members
02/02/2012US20120027813 Adjuvanted influenza vaccines for pediatric use
02/02/2012US20120027811 Formulations of Viable Cells for Oral Delivery
02/02/2012US20120027808 Nicotine immunonanotherapeutics
02/02/2012US20120027806 Dose selection of adjuvanted synthetic nanocarriers
02/02/2012US20120027801 Polypeptides from neisseria meningitidis
02/02/2012US20120027800 Neisserial vaccine compositions comprising a combination of antigens
02/02/2012US20120027799 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
02/02/2012US20120027798 Antibody gene transfer and recombinant aav therefor
02/02/2012US20120027797 Preservation of Bioactive Materials by Freeze Dried Foam
02/02/2012US20120027796 Novel lipids and compositions for the delivery of therapeutics
02/02/2012US20120027795 Simple vaccines from dna launched suicidal flaviviruses
02/02/2012US20120027794 Tuberculosis vaccine with improved efficacy
02/02/2012US20120027793 Compositions comprising chlamydia antigens
02/02/2012US20120027792 Expression vectors able to elicit improved immune response and methods of using same
02/02/2012US20120027790 Immunological herpes simplex virus antigens and methods for use thereof
02/02/2012US20120027789 Antigenic peptide of hsv-2 and methods for using same
02/02/2012US20120027788 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
02/02/2012US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
02/02/2012US20120027786 Genetically programmable pathogen sense and destroy
02/02/2012US20120027785 Chimera comprising bacterial cytotoxin and methods of using the same
02/02/2012US20120027784 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027783 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027782 Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7)
02/02/2012US20120027780 Anticoagulant antidotes
02/02/2012US20120027779 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
02/02/2012US20120027778 Frizzled-Binding Agents and Uses Thereof
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027776 Diabetic model
02/02/2012US20120027775 Absorbable peg-based hydrogels
02/02/2012US20120027774 Metalloproteinase 9 binding proteins
02/02/2012US20120027773 Anti-ron antibodies
02/02/2012US20120027772 Therapeutic protein formulations
02/02/2012US20120027771 Affinity purified human polyclonal antibodies against viral, bacterial and/or fungal infections and methods of making and using the same
02/02/2012US20120027770 Novel cell and therapeutical and diagnostical methods based thereon
02/02/2012US20120027769 Anti-rhd monoclonal antibodies
02/02/2012US20120027768 Monoclonal antibody production by ebv transformation of b cells
02/02/2012US20120027767 Antibodies against pdgfr alpha to inhibit tumor growth
02/02/2012US20120027766 Methods and means for treatment of osteoarthritis
02/02/2012US20120027765 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
02/02/2012US20120027764 Novel polypeptide, cdna encoding the same, and use thereof
02/02/2012US20120027763 Antibody for Targeted induction of Apoptosis, CDC and ADCC mediated killing of Cancer cells, TBL-CLN1
02/02/2012US20120027762 Immunogenic compositions and diagnostic and therapeutic uses thereof
02/02/2012US20120027761 Treatment of Inflammatory Diseases by Inhibiting Cold-Inducible RNA-Binding Protein (CIRP)
02/02/2012US20120027760 Adiponectin receptor and gene encoding the same
02/02/2012US20120027759 Methods of enhancing t cell responsiveness
02/02/2012US20120027758 Use of anti-cd100 antibodies
02/02/2012US20120027757 Compositions and methods for treating cancer
02/02/2012US20120027756 Methods and compositions for treating allergic diseases
02/02/2012US20120027755 Prevention and treatment of alzheimer's disease
02/02/2012US20120027754 Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
02/02/2012US20120027753 MicroRNAs in Never-Smokers and Related Materials and Methods
02/02/2012US20120027752 Methods and compounds for treating paramyxoviridae virus infections
02/02/2012US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
02/02/2012US20120027750 Method and compositions for cancer prognosis
02/02/2012US20120027749 Method
02/02/2012US20120027748 Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
02/02/2012US20120027721 HCV Inhibitor and Therapeutic Agent Combinations
02/02/2012US20120027720 Peptide conjugates
02/02/2012US20120027686 Hk1-binding proteins
02/02/2012US20120027684 Cancer therapy based on tumor associated antigens derived from cyclin d1
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012US20120027674 Il-18 receptor as a novel target of regulatory t cells in cancer
02/02/2012CA2806909A1 Safe and functional humanized antibodies
02/02/2012CA2806613A1 Recombinant neisseria meningitidis pora porin proteins
02/02/2012CA2806536A1 Recombinant bacterium and uses thereof
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 1823